Efficacy and safety of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in diabetic nephropathy: a meta-analysis

被引：0
|
作者：
Mao-Lu Tian
Yan Shen
Zhao-Lin Sun
Yan Zha
机构：
[1] Guizhou Provincial People’s Hospital,Institute of Nephritic and Urinary Disease, Department of Nephrology
[2] Guizhou Provincial People’s Hospital,Institute of Nephritic and Urinary Disease, Department of Urology
来源：
International Urology and Nephrology | 2015年 / 47卷
关键词：
Diabetic nephropathy; Pentoxifylline; Angiotensin-converting enzyme inhibitors; Angiotensin receptor blockers; Randomized controlled trails;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：815 / 822
页数：7
相关论文
共 50 条
  • [21] Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
    Zhang, Chao
    Zhong, Jun
    Chen, Wei-Xiang
    Zhang, Xu-Yang
    Li, Yu-Hong
    Zhou, Teng-Yuan
    Zou, Yong-Jie
    Lan, Chuan
    Li, Lan
    Lai, Zhao-Pan
    Feng, Hua
    Hu, Rong
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 355 - 363
  • [22] Clinical effect of mineralocorticoid receptor antagonist combined with angiotensin receptor blocker or angiotensin converting enzyme inhibitor in treating diabetic nephropathy: a systematic review and meta-analysis
    Li, Yaoyao
    Xu, Bin
    He, Lei
    Li, Mengsi
    Zhao, Tianya
    Wu, Xiaoyan
    Gao, Ping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (06): : 5395 - 5408
  • [23] Retrospective Review of Exceptions for Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Recommendations for a Diabetic Medicare Population
    Chinthammit, Chanadda
    Harrington, Amanda
    Wild, Ann
    Werner, Shepin
    Boesen, Kevin
    Taylor, Ann M.
    Warholak, Terri L.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (03): : 358 - +
  • [24] Paradoxical pressor response with angiotensin-converting enzyme inhibitor and angiotensin receptor blocker
    Sabitha, P.
    Adhikari, Prabha M.
    AUSTRALASIAN MEDICAL JOURNAL, 2011, 4 (07): : 364 - +
  • [25] Effects of combination therapy of an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker
    Idrizi, A
    Gjata, M
    Barbullushi, M
    Koroshi, A
    Tase, M
    Sadiku, E
    Hoti, K
    JOURNAL OF HYPERTENSION, 2005, 23 : S398 - S398
  • [26] Efficacy and safety of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for IgA nephropathy in children
    Vaz de Castro, Pedro Alves Soares
    Bitencourt, Leticia
    Pereira, Bruno Wilnes Simas
    Lima, Ananda Queiroz Rocha
    Hermida, Henrique Santos
    Moreira Neto, Carlos Roberto
    Mestriner, Mariana Dinamarco
    Simoes e Silva, Ana Cristina
    PEDIATRIC NEPHROLOGY, 2022, 37 (03) : 499 - 508
  • [27] Efficacy and safety of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for IgA nephropathy in children
    Pedro Alves Soares Vaz de Castro
    Letícia Bitencourt
    Bruno Wilnes Simas Pereira
    Ananda Queiroz Rocha Lima
    Henrique Santos Hermida
    Carlos Roberto Moreira Neto
    Mariana Dinamarco Mestriner
    Ana Cristina Simões e Silva
    Pediatric Nephrology, 2022, 37 : 499 - 508
  • [28] Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril
    Boenner, G.
    Bakris, G. L.
    Sica, D.
    Weber, M. A.
    White, W. B.
    Perez, A.
    Cao, C.
    Handley, A.
    Kupfer, S.
    JOURNAL OF HUMAN HYPERTENSION, 2013, 27 (08) : 479 - 486
  • [29] Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril
    G Bönner
    G L Bakris
    D Sica
    M A Weber
    W B White
    A Perez
    C Cao
    A Handley
    S Kupfer
    Journal of Human Hypertension, 2013, 27 : 479 - 486
  • [30] Will the addition of pentoxifylline reduce proteinuria in patients with diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker?
    Diskin, Charles J.
    Stokes, Thomas J.
    Dansby, Linda M.
    Radcliff, Lautrec
    Carter, Thomas B.
    JOURNAL OF NEPHROLOGY, 2007, 20 (04) : 410 - 416
12345